|
Delayed
London S.E.
11:35:00 2026-11-19 EST
|
5-day change | 1st Jan Change | ||
| 13.60 GBX | 0.00% |
|
0.00% | -17.33% |
| 11-10 | WINNERS & LOSERS: EDX rises on test launch, Zanaga down on deal delay | AN |
| 11-03 | WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan | AN |
Company Valuation: LMS Capital plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 24.22 | 29.06 | 23.81 | 19.78 | 13.56 | 13.28 |
| Change | - | 20% | -18.06% | -16.95% | -31.43% | -2.08% |
| Enterprise Value (EV) 1 | 7.935 | 14.62 | 50.35 | 13.29 | 2.853 | 6.716 |
| Change | - | 84.23% | 244.43% | -73.6% | -78.53% | 135.37% |
| P/E | -5.51x | 15.7x | -12.7x | -5.3x | -2.53x | -2.35x |
| PBR | 0.51x | 0.59x | 0.51x | 0.47x | 0.38x | 0.46x |
| PEG | - | -0x | 0x | -0.1x | -0.1x | -0.42x |
| Capitalization / Revenue | -7.68x | 7.53x | 331x | -12.9x | -4.26x | 32.2x |
| EV / Revenue | -2.52x | 3.79x | 699x | -8.65x | -0.9x | 16.3x |
| EV / EBITDA | -1.7x | 7.2x | -26.9x | -3.6x | -0.57x | -1.22x |
| EV / EBIT | -1.7x | 7.3x | -26.5x | -3.58x | -0.57x | -1.22x |
| EV / FCF | -0.12x | 11.2x | -46.1x | -5.81x | -0.88x | -1.96x |
| FCF Yield | -847% | 8.95% | -2.17% | -17.2% | -114% | -51% |
| Dividend per Share 2 | 0.009 | 0.00925 | 0.00925 | 0.00925 | 0.003 | - |
| Rate of return | 3% | 2.57% | 3.14% | 3.78% | 1.79% | - |
| EPS 2 | -0.0545 | 0.023 | -0.0232 | -0.0462 | -0.0663 | -0.07 |
| Distribution rate | -16.5% | 40.2% | -39.8% | -20% | -4.52% | - |
| Net sales 1 | -3.153 | 3.86 | 0.072 | -1.536 | -3.181 | 0.412 |
| EBITDA 1 | -4.657 | 2.03 | -1.871 | -3.687 | -5.001 | -5.511 |
| EBIT 1 | -4.671 | 2.002 | -1.898 | -3.715 | -5.029 | -5.525 |
| Net income 1 | -4.396 | 1.872 | -1.874 | -3.732 | -5.354 | -5.611 |
| Net Debt 1 | -16.28 | -14.44 | 26.54 | -6.487 | -10.71 | -6.564 |
| Reference price 2 | 0.3000 | 0.3600 | 0.2950 | 0.2450 | 0.1680 | 0.1645 |
| Nbr of stocks (in thousands) | 80,727 | 80,727 | 80,727 | 80,727 | 80,727 | 80,727 |
| Announcement Date | 4/8/21 | 4/21/22 | 4/19/23 | 3/18/24 | 3/26/25 | 3/23/26 |
1GBP in Million2GBP
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 14.39M | ||
| 21.57x | 5.87x | 12.69x | 2.02% | 175B | ||
| 13.52x | 3.25x | - | 2.65% | 138B | ||
| 15.51x | 7.16x | - | 1.59% | 97.46B | ||
| 19.48x | 6.93x | 12.34x | 4.39% | 92.76B | ||
| 18.4x | 11.06x | 17.09x | 0.85% | 82.19B | ||
| 20.47x | 12.82x | 22.27x | 3.98% | 80.45B | ||
| 11.99x | 4.67x | - | 2.17% | 43.87B | ||
| 10.63x | 1.56x | 4.86x | 1.37% | 42.74B | ||
| Average | 16.45x | 6.67x | 13.85x | 2.38% | 84B | |
| Weighted average by Cap. | 17.41x | 6.68x | 14.31x | 2.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LMS Stock
- Valuation LMS Capital plc
Select your edition
All financial news and data tailored to specific country editions
















